Subsequent comparisons of clinical characteristics among the three groups revealed that the proportion of patients with lymph node metastasis was the highest in the OCT4+CTC group, followed by the none CTC group, and was the lowest in the OCT4−CTC group. Here, POU5F1 is linked to metastatic malignant neoplasm in the lymph nodes.